Schonfeld Strategic Advisors’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$121K Buy
+12,399
New +$114K ﹤0.01% 1853
2025
Q3
Sell
-307,341
Closed -$1.87M 2497
2025
Q2
$1.87M Buy
+307,341
New +$2.31M 0.01% 1025
2024
Q4
Sell
-62,272
Closed -$1.04M 2308
2024
Q3
$1.04M Buy
+62,272
New +$1.34M 0.01% 1146
2023
Q1
Sell
-28,128
Closed -$1.69M 2530
2022
Q4
$1.69M Sell
28,128
-16,662
-37% -$976K 0.01% 893
2022
Q3
$2.72M Buy
+44,790
New +$1.42M 0.02% 744
2022
Q1
Sell
-10,387
Closed -$513K 2855
2021
Q4
$513K Buy
10,387
+6,622
+176% +$367K ﹤0.01% 1242
2021
Q3
$269K Buy
+3,765
New +$234K ﹤0.01% 1588

Other funds holding PRTA

Schonfeld Strategic Advisors's PRTA Position: Q1 2026 in Review

Schonfeld Strategic Advisors opened a new position in Prothena Corp (PRTA) in Q1 2026: 12,399 shares worth $121K. The stake represents ﹤0.01% of the portfolio and ranks #1853 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in PRTA as recently as Q2 2025.

Schonfeld Strategic Advisors first reported a position in PRTA in Q3 2021 and has held it in 7 quarters since. The position peaked at $2.72M in Q3 2022. 185 funds tracked by Wall St. Rank hold PRTA as of Q1 2026.

  • Schonfeld Strategic Advisors held 12,399 shares of Prothena Corp worth $121K as of Q1 2026.
  • Prothena Corp was a new Schonfeld Strategic Advisors position in Q1 2026.
  • Prothena Corp made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #1853 holding.
  • Schonfeld Strategic Advisors first reported a position in Prothena Corp in Q3 2021 and has held it in 7 quarters since.
  • Schonfeld Strategic Advisors's Prothena Corp position peaked at $2.72M in Q3 2022.
  • 185 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.